Scientists have named three relatively little-known diseases they think could cause the next global health emergency. A coalition of governments and charities has committed $460m to speed up vaccine development for MERS (Middle East Respiratory Syndrome), Lassa fever and Nipah virus. At the Jenner Institute, scientists are developing vaccines for all three of the viruses. Their MERS vaccine candidate is currently at the most advanced stage worldwide. It is expected that it will be trialled in humans by the end of the year.
Jenner Institute scientists, Dr Lynda Coughlan and Prof Adrian Hill have been awarded the 2016 British Medical Association HC Roscoe grant for a research project which aims to develop improved vaccines for influenza. Fifteen medical academics and research scientists were awarded a total of ...
UK researchers creating new vaccines for epidemic diseases such as Zika and Ebola are among the winners of £22 million of funding, announced by the Department of Health today. These projects will be the first to benefit from the UK Vaccine Network, a £120 million fund launched last year to support Britain’s world-leading role fighting deadly diseases. The network brings together leading figures from industry, academia and philanthropy, including the Jenner Institute, University of Oxford, the Wellcome Trust, and GlaxoSmithKline (GSK).
In this issue, there is a particular highlight on Outbreak Pathogens. In the past months, Jenner researchers have received major funding to manufacture and clinically develop vaccine candidates against several outbreak pathogens of international concern: Zika, Chikungunya, MERS and Rift Valley Fever. Recently, the Jenner Institute has also initiated research programmes on vaccines against non-communicable diseases such as prostate cancer and psoriasis, and Prof Lucy Dorrell’s group is utilizing the Jenner Institute’s viral vector prime-boost platform to deliver therapeutic vaccine against cervical pre-cancer.
'Going Viral' is the first in a new series of audio podcasts. This episode, featuring Dr Sandy Douglas from the Jenner Institute, explores how we learn to use viruses to our own advantage, in fighting them with vaccines as well as harnessing them for use in understanding how the brain is connected.
The University of Oxford ranks Number 1 in the latest Times Higher Education (THE) World University Rankings. Oxford becomes the first British university ever to occupy top position in the global table, which judges the performance of 980 universities across 79 countries.
The University of Oxford's Professor Sir Peter Ratcliffe has won the Albert Lasker Basic Medical Research Award, one of the most prestigious prizes in medicine, for his work understanding the mechanisms by which cells sense and signal hypoxia (low oxygen levels). Hypoxia is an important component of many human diseases including cancer, heart disease, stroke, vascular disease, and anaemia.
From pre-clinical testing to field trials - development and manufacture of vaccines, immunogenicity and vaccine testing in Phases I to IV .21-25 Nov: Human and Veterinary Vaccinology
5 day Master's level course providing an overview of all aspects of human and veterinary vaccinology - from Edward Jenner to modern day vaccines.
While HIV is no longer the death sentence it once was, we are yet to defeat it entirely. However, a new study from Oxford University offers hope that HIV will eventually have nowhere to hide. Tom Calver spoke to Professor Lucy Dorrell (Jenner Investigator) about her work on clearing HIV from the body.
CONACyT will fund through its 2016 “Frontiers of Science” call a project submitted by Dr Héctor Vivanco Cid of Universidad Veracruzana in collaboration with Prof Reyes-Sandoval Group, The Jenner Institute, Nuffield Department of Medicine. The study will take place in in the sate of Veracruz, which has had the highest numbers of cases of dengue fever and dengue haemorrhagic fever in Mexico in recent years, and the highest number of hospitalisations due to this disease. It is expected that chikungunya and zika viruses will become endemic in this region as well.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.